Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
about
Oral contraceptives containing drospirenone for premenstrual syndromeOral contraceptives containing drospirenone for premenstrual syndromeThe role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatmentNeurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functionsReproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?Clinical epidemiology of premenstrual disorder: informing optimized patient outcomesTreatment of premenstrual dysphoric disorderPremenstrual dysphoric disorder: evidence for a new category for DSM-5Update on research and treatment of premenstrual dysphoric disorder.Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorderLifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women's SurveyPhysiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills.Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol.Current methods and attitudes of women towards contraception in Europe and America.Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms.Premenstrual dysphoric disorder: burden of illness and treatment update.Drospirenone: a novel progestin.Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.A reproductive subtype of depression: conceptualizing models and moving toward etiology.The association of migraine with menstrually related mood disorders and childhood sexual abuse.Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin.ISPMD consensus on the management of premenstrual disorders.Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.Therapeutic management of premenstrual syndrome.Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits.The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium.Adverse mood symptoms with oral contraceptives.Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome.Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder.Yasminelle((R)): a new low-dose combined oral contraceptive containing drospirenone.Hormones in the treatment of depression.Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies.A controlled trial of Chinese herbal medicine for premenstrual syndrome.Hormonal contraception and depression: another Pill scandal?Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial.Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.
P2860
Q24203717-671BF7DD-5066-4484-874F-D40EAE1CCCFBQ24240981-7704AD13-520C-4C13-B0D6-369110AB3244Q24561815-F37A53F4-CC0D-421D-B183-4D5A8B4D9864Q24618586-F9979A62-31E1-4198-B37E-1F0D88E07C17Q24650090-99FA5370-D3E3-4287-BB16-811EA8A56A8DQ26785607-E81D37ED-7A70-470E-979B-F1A22A503FD0Q28300895-1754D4C5-D7C3-4D45-8953-1CDDD7B2F08AQ30462752-25FC4A61-0768-4F32-970C-B1AD075AFC86Q30475462-ED331218-34E4-4621-AAFD-9E76AB230F38Q34272049-BD9808AB-A4E8-447B-AE14-E4E78A45E26AQ34962155-804F4FEE-8457-4F3A-9A29-49D1C46E41E9Q36573746-9A21F472-F3C9-47CA-B604-7746A1330516Q36642976-F5E97B2D-A038-4A90-A80A-1D3D11F71576Q36689573-3D7D5E68-13DE-4925-B9D1-2834C8A6BD96Q36716452-B14E8586-C0B9-421C-B630-CC908571A85DQ36720116-F1CD9517-134C-4771-AEAE-CFFF5ED13768Q36737964-491E6036-2C6B-404C-8E66-AF2AD0CCFAF7Q36808051-D87BE5DA-F35A-4858-BC26-319CF4340C81Q37030687-27E10BDE-16F3-40E9-9AF0-EE3716275D9DQ37089316-A5796B6A-9358-4DE4-821B-981C6D6185D1Q37208182-1B0C8B24-F7CA-4DEC-8C41-610C3A77E0F6Q37423681-C588E17B-1828-4533-A2DA-FCE987310204Q37638987-A62AF3B2-5289-4CD6-8633-F5747FAD8ABBQ37724251-45177B43-E802-42F4-9E4D-669488747D53Q37778061-9B6F2295-7AAF-48EA-B326-46D357CBB0DEQ37822793-3FFD4916-E082-486D-BC16-0BCC3293F363Q37923956-AEF20ABD-34EA-4302-AA4E-125AF9A2F939Q37963994-937A91E1-54F2-4DA7-8BA5-A4DE82BA6263Q38093136-FC4E0E1D-4E60-4FF7-85C7-55E03C9D1DBDQ38513642-F1B3CD9B-D4A5-48BA-8C55-B5AA54F07C23Q40234284-3D55D37B-C890-41BD-979C-C8E04B4E41FFQ40472214-A346ACA5-35CA-41AA-83F9-5D0659E4C061Q43267026-15C02BEE-9970-4F60-889C-C6CDD4FC68E0Q43267039-EE6DF839-7FFA-408B-8581-3810F2E163F3Q43267057-4A27F6AA-1125-4E6D-AF68-0127BE814662Q47549801-6CAAD9F2-BA74-4664-85F0-50C24F3C67F8Q47672085-618EDDFE-8D89-4F70-9660-0A82BC4FBE53Q47978194-B84A3AC3-5520-425E-A1A8-CE6D4871CFAFQ48040189-A11C4265-2335-41CA-9BB1-DC27478E05FDQ48113811-8BE2E23C-DF14-4456-95A5-896DCCB113BC
P2860
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@en
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@nl
type
label
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@en
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@nl
prefLabel
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@en
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@nl
P2093
P1433
P1476
Treatment of premenstrual dysp ...... ral contraceptive formulation.
@en
P2093
Gloria A Bachmann
Howard A Zacur
Teri B Pearlstein
P304
P356
10.1016/J.CONTRACEPTION.2005.08.021
P577
2005-11-02T00:00:00Z